Plasma proteomic and metabolomic signatures of B-ALL patients during CAR-T cell therapy-2

ABSTRACT: The study aimed to assess plasma proteomic and metabolomic profiling in patients with B-ALL during humanized anti-CD19-CAR-T cell therapy

ORGANISM(S): Homo Sapiens

SUBMITTER: Jianghua Wu  

PROVIDER: PXD040411 | iProX | Mon Feb 27 00:00:00 GMT 2023

REPOSITORIES: iProX